Conmed (CNMD) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44% |
| Dec 31, 2025 | 10.17% |
| Sep 30, 2025 | 9.55% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | 5.99% |
| Dec 31, 2024 | -8.18% |
| Sep 30, 2024 | -6.83% |
| Jun 30, 2024 | -6.35% |
| Mar 31, 2024 | -12.74% |
| Dec 31, 2023 | 0.41% |
| Sep 30, 2023 | 3.88% |
| Jun 30, 2023 | 5.24% |
| Mar 31, 2023 | 2.37% |
| Dec 31, 2022 | 9.47% |
| Sep 30, 2022 | 12.60% |
| Jun 30, 2022 | 14.19% |
| Mar 31, 2022 | 7.37% |
| Dec 31, 2021 | -5.88% |
| Sep 30, 2021 | 15.02% |
| Jun 30, 2021 | -9.30% |
| Mar 31, 2021 | 2.20% |
| Dec 31, 2020 | -2.26% |
| Sep 30, 2020 | -2.31% |
| Jun 30, 2020 | 0.16% |
| Mar 31, 2020 | -7.00% |
| Dec 31, 2019 | 14.39% |
| Sep 30, 2019 | 6.17% |
| Jun 30, 2019 | 1.72% |
| Mar 31, 2019 | -0.21% |
| Dec 31, 2018 | -0.57% |
| Sep 30, 2018 | -3.58% |
| Jun 30, 2018 | -2.93% |
| Mar 31, 2018 | -1.74% |
| Dec 31, 2017 | -8.29% |
| Sep 30, 2017 | -3.25% |
| Jun 30, 2017 | -10.68% |
| Mar 31, 2017 | -16.65% |
| Dec 31, 2016 | -2.42% |
| Sep 30, 2016 | -7.53% |
| Jun 30, 2016 | 1.93% |
| Mar 31, 2016 | -7.61% |
| Dec 31, 2015 | -1.85% |
| Sep 30, 2015 | -27.16% |